Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Meridian Bioscience (VIVO)

22.21   -0.69 (-3.01%) 01-27 02:30
Open: 23 Pre. Close: 22.9
High: 23.2 Low: 22.09
Volume: 297,497 Market Cap: 958M
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for various gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms and technologies, including real-time PCR amplification under the Revogene brand; isothermal DNA amplification under the Alethia brand; rapid fluorescence-based immunoassay platform under the Curian brand; rapid single-use immunoassays under the ImmunoCard and ImmunoCard STAT! brand names; enzyme-linked immunoassays under the PREMIER brand; and anodic stripping voltammetry, an electrical chemical sensor platform for quantitative determination under the LeadCare and PediaStat brands. This segment's products are primarily used in the detection of infectious diseases caused by various bacteria, viruses, parasites, and pathogens. Its products consists of gastrointestinal assays, including tests for C. difficile, Enterohemorrhagic E. coli, Campylobacter jejuni, H. pylori, Cryptosporidium, giardia lamblia, and calprotectin; respiratory illness assays, such as tests for Group A Streptococcus, Influenza, M. pneumoniae, Bordetella pertussis, and respiratory syncytial virus; blood chemistry assays; and tests for Group B Streptococcus, Chlamydia trachomatis, Neisseria gonorrhea, Herpes Simplex Virus Type 1 and Type 2, and Malaria. This segment sells its products through direct sales force and independent distributors to acute care hospitals, reference laboratories, outpatient clinics, and physician office laboratories. The Life Science segment offers bulk antigens, antibodies, PCR/qPCR reagents, nucleotides, and bioresearch reagents used by researchers, agri-bio companies, and IVD manufacturing companies. Meridian Bioscience, Inc. was incorporated in 1976 and is headquartered in Cincinnati, Ohio.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 23.245 - 23.377 23.377 - 23.52
Low: 21.729 - 21.872 21.872 - 22.027
Close: 21.941 - 22.189 22.189 - 22.458

Technical analysis

as of: 2021-01-26 4:50:11 PM
Overall:       
Stoxline posted a STRONG SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 27.32     One year: 31.91
Support: Support1: 20.42    Support2: 18.58
Resistance: Resistance1: 23.39    Resistance2: 27.32
Pivot: 22.05
Moving Average: MA(5): 22.70     MA(20): 21.40
MA(100): 18.58     MA(250): 16.14
MACD: MACD(12,26): 0.81     Signal(9): 0.79
Stochastic oscillator: %K(14,3): 85.30     %D(3): 89.77
RSI: RSI(14): 56.79
52-week: High: 26.58  Low: 5.51  Change(%): 112.3
Average Vol(K): 3-Month: 54208  10-Days: 35600

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
VIVO has closed below upper band by 44.6%. Bollinger Bands are 21.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Fri, 22 Jan 2021
Meridian Bioscience Inc. (VIVO) Soars 1.64% on January 22 - Equities.com

Thu, 21 Jan 2021
Meridian Bioscience (VIVO) Stock Sinks As Market Gains: What You Should Know - Nasdaq

Wed, 20 Jan 2021
Why the Earnings Surprise Streak Could Continue for Meridian Bioscience (VIVO) - Yahoo Finance

Tue, 19 Jan 2021
Meridian Bioscience Inc. (VIVO) Soars 5.79% on January 19 - Equities.com

Thu, 14 Jan 2021
Meridian Bioscience (VIVO) Gains As Market Dips: What You Should Know - Yahoo Finance

Wed, 13 Jan 2021
Meridian Bioscience to Hold First Quarter Fiscal 2021 Financial Results Conference Call on February 5, 2021 - Yahoo Finance

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Outperform
Return on Equity: Neutral Debt to Equity: Outperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Diagnostics & Research
Shares Out. (M) 43
Shares Float (M) 38
% Held by Insiders 0.70
% Held by Institutions 94.07
Shares Short (K) 3,700
Shares Short P. Month (K) 3,440

Stock Financials

EPS 1.070
EPS Est This Year 0.670
EPS Est Next Year 0.670
Book Value (p.s.) 5.750
Profit Margin 18.21
Operating Margin 24.32
Return on Assets (ttm) 10.6
Return on Equity (ttm) 21.1
Qtrly Rev. Growth 26.2
Gross Profit (p.s.) 3.624
Sales Per Share 5.883
EBITDA (p.s.) 1.745
Qtrly Earnings Growth 58.30
Operating Cash Flow (M) 48
Levered Free Cash Flow (M) 54

Stock Valuations

PE Ratio 20.76
PEG Ratio
Price to Book value 3.86
Price to Sales 3.78
Price to Cash Flow 19.96

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date 2019-02-13
Ex-Dividend Date 2019-01-31
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.